Skip to main content

Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome.


AUTHORS

Maalouf FI , Cooper WO , Slaughter JC , Dudley J , Patrick SW , . The Journal of pediatrics. 2018 5 7; ().
  • NIHMSID: 0375410

ABSTRACT

To determine differences in lengths of stay, length of therapy, emergency department (ED) utilization, and hospital readmissions between infants with neonatal abstinence syndrome (NAS) treated exclusively with inpatient pharmacotherapy compared with those discharged on outpatient pharmacotherapy.


To determine differences in lengths of stay, length of therapy, emergency department (ED) utilization, and hospital readmissions between infants with neonatal abstinence syndrome (NAS) treated exclusively with inpatient pharmacotherapy compared with those discharged on outpatient pharmacotherapy.


Tags: